Similarly, analysis of autophagic markers in the basal ganglia of LRRK2-G2019S patient post-mortem tissue showed a decrease in p62 and LAMP1 in comparison to matched idiopathic PD patients, assessed both by immunohistochemistry and immunoblotting (Mamais et al., 2018). Here, LRRK2 is linked to Parkinson disease.